New England Compounding Center
A federal grand jury has begun to hand down subpoenas in its investigation of the deadly meningitis outbreak linked to a Framingham pharmacy.
The owner and director of the specialty pharmacy tied to a deadly meningitis outbreak declined to testify Wednesday morning before a congressional committee investigating the matter.
The head of the Massachusetts health department says investigators still don’t know why regulators backed off a severe penalty against the New England Compounding Center in 2004.
Nearly a decade ago, federal health inspectors wanted to shut down the Framingham pharmacy linked to a recent deadly meningitis outbreak until it cleaned up its operations, according to congressional investigators.
One by one, about a dozen people showed up to the Ameridose facility in Westborough on Friday, only to be turned away the door.
A company spokesman says the notice affects 650 employees at Ameridose and 140 employees at its marketing and support arm.
The Director of the Massachusetts Board of Pharmacy has been fired amid an investigation into New England Compounding Center’s role in the nation-wide meningitis outbreak.
A company with the same founders as a specialty pharmacy tied to a deadly meningitis outbreak has agreed to extend its voluntary closure until Nov. 19.
The compounding pharmacy in Framingham blamed for a national fungal meningitis outbreak reportedly sent customers a “quality assurance report card” just before people started getting sick.
The Department of Public Health has revoked the license of another compounding pharmacy in the state.